Cargando…
Sox2 is necessary for androgen ablation-induced neuroendocrine differentiation from Pten null Sca-1(+) prostate luminal cells
Prostate adenocarcinoma undergoes neuroendocrine differentiation to acquire resistance toward anti-hormonal therapies. The underlying mechanisms have been investigated extensively, among which Sox2 has been shown to play a critical role. However, genetic evidence in mouse models for prostate cancer...
Autores principales: | Kwon, Oh-Joon, Zhang, Li, Jia, Deyong, Xin, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796948/ https://www.ncbi.nlm.nih.gov/pubmed/33110232 http://dx.doi.org/10.1038/s41388-020-01526-2 |
Ejemplares similares
-
De novo induction of lineage plasticity from human prostate luminal epithelial cells by activated AKT1 and c-Myc
por: Kwon, Oh-Joon, et al.
Publicado: (2020) -
Altered Proliferative Response by T Lymphocytes of Ly-6A (Sca-1) Null Mice
por: Stanford, William L., et al.
Publicado: (1997) -
PTEN deletion in luminal cells of mature prostate induces replication stress and senescence in vivo
por: Parisotto, Maxime, et al.
Publicado: (2018) -
TIP5 primes prostate luminal cells for the oncogenic transformation mediated by PTEN-loss
por: Pietrzak, Karolina, et al.
Publicado: (2020) -
Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer
por: Su, Qingtai, et al.
Publicado: (2016)